Amgen Inc. (TSX:AMGN)

Canada · Delayed Price · Currency is CAD

25.61

-0.19 (-0.74%)

At close: Feb 3, 2026

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Prolia Revenue	4.41B
ENBREL Revenue	2.23B
XGEVA Revenue	2.08B
Repatha Revenue	3.02B
Otezla Revenue	2.27B
TEPEZZA Revenue	1.90B
EVENITY Revenue	2.10B
KYPROLIS Revenue	1.41B
Nplate Revenue	1.52B
Aranesp Revenue	1.39B
BLINCYTO Revenue	1.56B
KRYSTEXXA Revenue	1.34B
Vectibix Revenue	1.18B
TEZSPIRE Revenue	1.48B
Other Products Revenue	7.26B
Product Revenue	35.15B
Other Revenue	1.60B
Revenue (Total)	36.75B

Updated Dec 31, 2025. Data Source: Fiscal.ai.